Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein L15 pseudogene 13 (RPL15P13) is a human pseudogene that shares sequence similarity with the protein-coding ribosomal protein L15 gene (RPL15)[6]. Pseudogenes are genomic DNA sequences similar to normal genes but typically nonfunctional; they do not encode functional proteins and do not perform known biological functions. RPL15P13 exists as a relic of gene duplication or retrotransposition and is dispersed in the human genome with no evidence of translation or physiological relevance[6]. The canonical functional gene, RPL15, encodes a component of the large ribosomal 60S subunit important in translation, but the RPL15P13 pseudogene itself neither produces protein nor is associated with therapeutic drug targeting or biomarker use[6][3][5].
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L15 pseudogene 13 (RPL15P13).